Skip to main content
Danielle Patterson

Danielle Patterson

🇺🇸 United States🏥 Johns Hopkins University School of MedicineMD, SM

Training and career​

  • Current position Associate professor of gynecology and obstetrics, Johns Hopkins University School of Medicine; operates at Johns Hopkins Bayview Medical Center1
  • Program director Urogynecology and Reconstructive Pelvic Surgery Fellowship, Johns Hopkins, with clinical training split between Johns Hopkins Bayview Medical Center and Greater Baltimore Medical Center12
  • Medical school The Ohio State University College of Medicine (2003)1
  • Residency Obstetrics and gynecology, The Ohio State University Wexner Medical Center (2007)1
  • Fellowship Female pelvic medicine and reconstructive surgery, Brigham and Women's Hospital (2010)1
  • Graduate degree ScM in epidemiology, Harvard School of Public Health (2011)1
  • Fellows trained Fellowship director for Johns Hopkins fellows whose thesis work she coauthored, including Preston Edge (2024) and Barbara Ha (2025)2

Contributions​

Her published work covers management of failed midurethral slings, cost-utility modeling of stress incontinence treatment, and claims-based outcome studies of prolapse surgery with Johns Hopkins fellows.345

  • Sling plication for recurrent stress incontinence (2010). Led a series of 20 women with recurrent stress incontinence after a synthetic midurethral sling in which midline plication of the sling under sedation gave subjective improvement in 85% at a median follow-up of 54.5 days, with no complications.3
  • Cost utility of stress incontinence treatment (2015). Senior author of a Markov decision model in which the incontinence pessary was the most cost-effective option at a willingness-to-pay threshold of $50,000 and surgery became the most cost-effective at $60,000.4
  • Reoperation after sacrocolpopexy with or without hysterectomy (2023). Senior author of a MarketScan cohort of 3463 women in which reoperation for prolapse (1.5%, 1.1% and 1.5%) and for mesh complications did not differ among supracervical hysterectomy, total hysterectomy and no hysterectomy.5

Footnotes​

  1. Danielle Patterson, MD, SM. Johns Hopkins Medicine. Accessed October 2026. ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  2. Urogynecology and Reconstructive Pelvic Surgery Fellowship. Johns Hopkins Medicine, Gynecology and Obstetrics. Accessed October 2026. ↩ ↩2

  3. Patterson D, Rajan S, Kohli N. "Sling plication for recurrent stress urinary incontinence." Female Pelvic Med Reconstr Surg. 2010;16(5):307–309. doi:10.1097/SPV.0b013e3181ed3fc3 ↩ ↩2

  4. Von Bargen E, Patterson D. "Cost utility of the treatment of stress urinary incontinence." Female Pelvic Med Reconstr Surg. 2015;21(3):150–153. doi:10.1097/SPV.0000000000000159 ↩ ↩2

  5. Kikuchi JY, Yanek LR, Handa VL, Chen CCG, Jacobs S, Blomquist J, Patterson D. "Prolapse and mesh reoperations following sacrocolpopexy: comparing supracervical hysterectomy, total hysterectomy, and no hysterectomy." Int Urogynecol J. 2023;34(1):135–145. doi:10.1007/s00192-022-05263-w ↩ ↩2